Striving for synergy: how to improve cancer immunotherapy through multiple agonist costimulation

Immunotherapy. 2013 Dec;5(12):1271-3. doi: 10.2217/imt.13.129.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Cytotoxicity, Immunologic / immunology
  • Humans
  • Immunotherapy / methods*
  • Neoplasms / immunology*
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Receptors, OX40 / agonists
  • Receptors, OX40 / immunology
  • Tumor Necrosis Factor Receptor Superfamily, Member 9 / agonists
  • Tumor Necrosis Factor Receptor Superfamily, Member 9 / immunology

Substances

  • Receptors, OX40
  • Tumor Necrosis Factor Receptor Superfamily, Member 9